DEVICE CATEGORY · PCH
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
A gastrointestinal pathogen panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal microbial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal infection aids in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation and other laboratory findings.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biofire Diagnostics, LLC | 510(k) clearance | Nov 6, 2026 | FDA | |
| Luminex Corporation | 510(k) clearance | May 19, 2026 | FDA | |
| QIAGEN GmbH | 510(k) clearance | Mar 9, 2026 | FDA | |
Xpert GI PanelK251721 | Cepheid | 510(k) clearance | Jan 16, 2026 | FDA |
Source information
Follow the FDA links to view the original records.


